The funds will be used to advance Agomab’s candidates through clinical trials, including AGMB-129 for patients with ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

Head of Investor Relations Welcome to the Q3 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide number 3. Here we have the usual ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

Sanofi SA (NASDAQ:SNY) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into exclusive negotiations to ...

As Sanofi prepares to halt U.S. marketing of its dengue vaccine in 2026, locally acquired infections in the country are ...

French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US ...

The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than ...

A health-care buyout has been sealed by an American firm against a rival Gallic offer. That’s despite the asset being a ...

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...

Sanofi to present dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria at ACAAI: Paris Saturday, October 26, 2024, 12:00 Hrs [IST] Positive data from the ...

US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France.